• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外用抗真菌 - 皮质类固醇组合药物的应用新趋势

Emerging Trends in the Use of Topical Antifungal-Corticosteroid Combinations.

作者信息

Mijaljica Dalibor, Spada Fabrizio, Harrison Ian P

机构信息

Department of Scientific Affairs, Ego Pharmaceuticals Pty Ltd., 21-31 Malcolm Road, Braeside, VIC 3195, Australia.

出版信息

J Fungi (Basel). 2022 Aug 1;8(8):812. doi: 10.3390/jof8080812.

DOI:10.3390/jof8080812
PMID:36012800
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9409645/
Abstract

A broad range of topical antifungal formulations containing miconazole or terbinafine as actives are commonly used as efficacious choices for combating fungal skin infections. Their many benefits, owing to their specific mechanism of action, include their ability to target the site of infection, enhance treatment efficacy and reduce the risk of systemic side effects. Their proven efficacy, and positioning in the treatment of fungal skin infections, is enhanced by high patient compliance, especially when appropriate vehicles such as creams, ointments and gels are used. However, inflammation as a result of fungal infection can often impede treatment, especially when combined with pruritus (itch), an unpleasant sensation that elicits an urge to scratch. The scratching that occurs in response to pruritus frequently accelerates skin damage, ultimately aggravating and spreading the fungal infection. To help overcome this issue, a topical antifungal-corticosteroid combination consisting of miconazole or terbinafine and corticosteroids of varying potencies should be used. Due to their inherent benefits, these topical antifungal-corticosteroid combinations can concomitantly and competently attenuate inflammation, relieve pruritus and treat fungal infection.

摘要

多种含有咪康唑或特比萘芬作为活性成分的局部用抗真菌制剂通常被用作对抗真菌性皮肤感染的有效选择。由于其特定的作用机制,它们有诸多益处,包括能够靶向感染部位、提高治疗效果以及降低全身性副作用的风险。高患者依从性提升了它们已被证实的疗效以及在真菌性皮肤感染治疗中的地位,尤其是当使用乳膏、软膏和凝胶等合适的剂型时。然而,真菌感染引起的炎症常常会妨碍治疗,特别是当伴有瘙痒(痒)时,瘙痒是一种令人不适的感觉,会引发搔抓冲动。因瘙痒而发生的搔抓常常会加速皮肤损伤,最终加重并扩散真菌感染。为帮助克服这一问题,应使用由咪康唑或特比萘芬与不同强度的皮质类固醇组成的局部用抗真菌 - 皮质类固醇复方制剂。由于其固有的益处,这些局部用抗真菌 - 皮质类固醇复方制剂可以同时有效地减轻炎症、缓解瘙痒并治疗真菌感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/9409645/122367179456/jof-08-00812-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/9409645/e68254c3c004/jof-08-00812-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/9409645/3127bba5f3ed/jof-08-00812-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/9409645/122367179456/jof-08-00812-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/9409645/e68254c3c004/jof-08-00812-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/9409645/3127bba5f3ed/jof-08-00812-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/9409645/122367179456/jof-08-00812-g003.jpg

相似文献

1
Emerging Trends in the Use of Topical Antifungal-Corticosteroid Combinations.外用抗真菌 - 皮质类固醇组合药物的应用新趋势
J Fungi (Basel). 2022 Aug 1;8(8):812. doi: 10.3390/jof8080812.
2
Topical antifungal treatments for tinea cruris and tinea corporis.股癣和体癣的外用抗真菌治疗。
Cochrane Database Syst Rev. 2014 Aug 4;2014(8):CD009992. doi: 10.1002/14651858.CD009992.pub2.
3
Fungal infections of the skin: infection process and antimycotic therapy.皮肤真菌感染:感染过程与抗真菌治疗
Curr Drug Targets. 2005 Dec;6(8):849-62. doi: 10.2174/138945005774912726.
4
Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.舍他康唑:皮肤科和妇科浅表真菌病治疗应用综述
Drugs. 2009;69(3):339-59. doi: 10.2165/00003495-200969030-00009.
5
Miconazole and terbinafine induced reactive oxygen species accumulation and topical toxicity in human keratinocytes.咪康唑和特比萘芬可诱导人角质形成细胞中活性氧的积累及局部毒性。
Drug Chem Toxicol. 2022 Mar;45(2):834-838. doi: 10.1080/01480545.2020.1778019. Epub 2020 Jun 14.
6
Topical therapy for fungal infections.真菌感染的局部治疗
Am J Clin Dermatol. 2004;5(6):443-51. doi: 10.2165/00128071-200405060-00009.
7
The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses.局部联合疗法在炎性皮肤真菌病治疗中的优势。
Mycoses. 2008 Sep;51 Suppl 4:16-26. doi: 10.1111/j.1439-0507.2008.01615.x.
8
Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.优化浅表皮肤真菌感染的局部抗真菌治疗:聚焦于用于皮肤癣菌病的萘替芬局部用药
J Drugs Dermatol. 2013 Nov;12(11 Suppl):s165-71.
9
DA 5505: a novel topical formulation of terbinafine that enhances skin penetration and retention.DA 5505:一种新型特比萘芬局部用制剂,可增强皮肤渗透和滞留能力。
Chem Pharm Bull (Tokyo). 2015;63(7):525-30. doi: 10.1248/cpb.c15-00108. Epub 2015 May 9.
10
Miconazole nitrate bearing ultraflexible liposomes for the treatment of fungal infection.载有超柔性脂质体的硝酸咪康唑用于治疗真菌感染。
J Liposome Res. 2014 Jun;24(2):163-9. doi: 10.3109/08982104.2013.871025. Epub 2014 Jan 30.

引用本文的文献

1
Optimization of LCD-Based 3D Printing for the Development of Clotrimazole-Coated Microneedle Systems.基于液晶显示器的三维打印用于克霉唑包衣微针系统开发的优化
Materials (Basel). 2025 Mar 31;18(7):1580. doi: 10.3390/ma18071580.
2
Bioinformatics-Driven mRNA-Based Vaccine Design for Controlling Tinea Cruris Induced by .基于生物信息学的信使核糖核酸疫苗设计用于控制由……引起的股癣
Pharmaceutics. 2024 Jul 25;16(8):983. doi: 10.3390/pharmaceutics16080983.
3
Caffeine Protects Keratinocytes from Infection and Behaves as an Antidermatophytic Agent.

本文引用的文献

1
Emerging Antifungal Targets and Strategies.新兴抗真菌靶点和策略。
Int J Mol Sci. 2022 Mar 2;23(5):2756. doi: 10.3390/ijms23052756.
2
Pathogenesis, Immunology and Management of Dermatophytosis.皮肤癣菌病的发病机制、免疫学及治疗
J Fungi (Basel). 2021 Dec 31;8(1):39. doi: 10.3390/jof8010039.
3
Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison.药物递送载体与化妆品保湿剂:综述与比较
咖啡因可保护角质形成细胞免受感染,并具有抗皮肤癣菌作用。
Int J Mol Sci. 2024 Jul 30;25(15):8303. doi: 10.3390/ijms25158303.
4
, an Emerging Drug-Resistant Dermatophyte: A Review of the Treatment Options.一种新兴的耐药皮肤癣菌:治疗选择综述
J Clin Med. 2024 Jun 18;13(12):3558. doi: 10.3390/jcm13123558.
Pharmaceutics. 2021 Nov 26;13(12):2012. doi: 10.3390/pharmaceutics13122012.
4
Five Functional Aspects of the Epidermal Barrier.表皮屏障的五个功能方面。
Int J Mol Sci. 2021 Oct 28;22(21):11676. doi: 10.3390/ijms222111676.
5
A Novel Approach to Assess the Potency of Topical Corticosteroids.一种评估外用糖皮质激素效力的新方法。
Pharmaceutics. 2021 Sep 13;13(9):1456. doi: 10.3390/pharmaceutics13091456.
6
Selection of an effective topical corticosteroid.选择一种有效的局部皮质类固醇。
Aust J Gen Pract. 2021 Sep;50(9):651-655. doi: 10.31128/AJGP-07-20-5507.
7
A Review on Antifungal Efficiency of Plant Extracts Entrenched Polysaccharide-Based Nanohydrogels.植物提取物强化多糖基纳米水凝胶的抗真菌效率研究综述。
Nutrients. 2021 Jun 15;13(6):2055. doi: 10.3390/nu13062055.
8
Challenges in exploring and manipulating the human skin microbiome.探索和操纵人类皮肤微生物组的挑战。
Microbiome. 2021 May 30;9(1):125. doi: 10.1186/s40168-021-01062-5.
9
Topical antifungal-corticosteroid fixed-drug combinations: Need for urgent action.局部用抗真菌 - 皮质类固醇复方制剂:亟需采取行动。
Indian J Pharmacol. 2021 Jan-Feb;53(1):82-84. doi: 10.4103/ijp.ijp_930_20.
10
Human Skin Microbiome: Impact of Intrinsic and Extrinsic Factors on Skin Microbiota.人类皮肤微生物群:内在和外在因素对皮肤微生物群的影响。
Microorganisms. 2021 Mar 5;9(3):543. doi: 10.3390/microorganisms9030543.